-
Vanda Pharmaceuticals Inc. et al v. Roxane Laboratories Inc. DC CAFC
- 1:13-cv-01973
- D. Del.
- Judge: Gregory M. Sleet
- Filed: 11/25/2013
- Closed: 08/25/2016
- Latest Docket Entry: 08/21/2018
- PACER
- Docket updated daily
5
Plaintiffs
1
Defendant
7
Accused
Products
1
Patent-in-Suit
1,005
Days in
Litigation
-
Vanda Pharmaceuticals Inc. et al v. Roxane Laboratories Inc. DC CAFC
- 1:13-cv-01973
- D. Del.
- Judge: Gregory M. Sleet
- Filed: 11/25/2013
- Closed: 08/25/2016
- Latest Docket Entry: 08/21/2018
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim | Outcome |
|---|---|
| All challenged claims |
Valid
Entry 193 |
-
Infringement
Roxane Laboratories Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| iloperidone tablets, 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg dosage strengths | US RE39,198 E1 |
3
|
Infringement
Entry 195
|
